Abstract

Clinical Image

Vulvar lipoma: A rare tumour

Aarti Chitkara*

Published: 05 May, 2021 | Volume 4 - Issue 2 | Pages: 072-072

A 26 year nulliparous woman presented to the OPD with complaint of painless swelling in the vulva for the last 1.5 years which gradually increased in size causing difficulty in walking. 

Read Full Article HTML DOI: 10.29328/journal.cjog.1001091 Cite this Article Read Full Article PDF

References

  1. Kehagias DT, Smyrniotis VE, Karvounis EE, Gouliamos AD, Creatsas G. Large lipoma of the vulva. Eur J Obstet Gynecol Reprod Biol. 1999; 84: 5-6. PubMed: https://pubmed.ncbi.nlm.nih.gov/10413218/
  2. Jayi S, Laadioui M, El Fatemi H, Fdili FZ, Bouguern H, et al. Vulvar lipoma: a case report. J Med Case Rep. 2014; 8: 203. PubMed: https://pubmed.ncbi.nlm.nih.gov/24946809/
  3. Odoi AT, Owusu-Bempah A, Dassah ET, Darkey DE, Quayson SE. Vulvar lipoma: is it so rare?. Ghana Med J. 2011; 45: 125-127. PubMed: https://pubmed.ncbi.nlm.nih.gov/22282580/

Figures:

Figure 1

Figure 1

Figure 1

Figure 2

Similar Articles

Recently Viewed

  • Metabolic profiling and antibacterial activity of Eryngium pristis Cham. & Schltdl. - prospecting for its use in the treatment of bacterial infections
    Laura Silva Fernandes, Ygor Ferreira Garcia da Costa, Martha Eunice de Bessa, Adriana Lucia Pires Ferreira, José Otávio do Amaral Corrêa, Glauciemar Del-Vechio Vieira, Orlando Vieira de Sousa, Ana Lúcia Santos de Matos Araújo, Paula C Castilho* and Maria Silvana Alves* Laura Silva Fernandes,Ygor Ferreira Garcia da Costa,Martha Eunice de Bessa,Adriana Lucia Pires Ferreira,José Otávio do Amaral Corrêa,Glauciemar Del-Vechio Vieira,Orlando Vieira de Sousa,Ana Lúcia Santos de Matos Araújo,Paula C Castilho*,Maria Silvana Alves*. Metabolic profiling and antibacterial activity of Eryngium pristis Cham. & Schltdl. - prospecting for its use in the treatment of bacterial infections. Arch Pharm Pharma Sci. 2021: doi: 10.29328/journal.apps.1001027; 5: 020-028
  • Criteria for paediatric oral liquid form
    Daniela Gavrus, Ferran Bossacoma Busquets*, Josep Maria Català, Joan Lluis Vinent Genestar and Miquel Villaronga Flaque Daniela Gavrus,Ferran Bossacoma Busquets*,Josep Maria Català,Joan Lluis Vinent Genestar,Miquel Villaronga Flaque. Criteria for paediatric oral liquid form. Arch Pharm Pharma Sci. 2021: doi: 10.29328/journal.apps.1001026; 5: 018-019
  • COVID-19 immunologic and toxicological implication: Innate immune sensor and immune escape
    Luisetto M*, Farhan Ahmad Khan, Khaled Edbey, Gamal Abdul Hamid, Mashori GR, Nili BA, Fiazza C, YesvI R and Latishev Yu O Luisetto M*,Farhan Ahmad Khan,Khaled Edbey,Gamal Abdul Hamid,Mashori GR,Nili BA,Fiazza C,YesvI R,Latishev Yu O. COVID-19 immunologic and toxicological implication: Innate immune sensor and immune escape. Arch Pharm Pharma Sci. 2021: doi: 10.29328/journal.apps.1001025; 5: 001-017
  • Production and characterization of staphylokinase enzyme from Staphylococcus aureus ASIA4
    Nourah Hassan Alzahrani and Fareed Shawky El-Shenawy* Nourah Hassan Alzahrani,Fareed Shawky El-Shenawy*. Production and characterization of staphylokinase enzyme from Staphylococcus aureus ASIA4. Arch Pharm Pharma Sci. 2020: doi: 10.29328/journal.apps.1001024; 4: 027-035
  • Anticancer activity of novel surface functionalized metal doped hydroxyapatite
    Saheli Pradhan*, Shouvik Mitra and Arunava Goswami Saheli Pradhan*,Shouvik Mitra,Arunava Goswami. Anticancer activity of novel surface functionalized metal doped hydroxyapatite. Arch Pharm Pharma Sci. 2020: doi: 10.29328/journal.apps.1001023; 4: 021-026

Read More

Most Viewed

Read More

Help ?